/PRNewswire/ The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive access to available records for over 1,000 option and evaluation deals, including contract documents where available.
This report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of option and evaluation agreements from 2014 to 2021.
There are two major forms of deal term that allow a party to a deal to secure rights to an asset subject to a future event namely, option and evaluation.